Back to Kallie® or All Extracts

Terpene Profile (Measured Values)

Total Terpene Content by Weight: 13.255% (~132.55mg/g)

Alpha-Pinene0.62%
(0.8mg/g)
Pine/Sharp
Beta-Pinene1.15%
(1.5mg/g)
Pine/Herbal
Myrcene2.37%
(3.1mg/g)
Herbal/Musk
Limonene8.94%
(11.8mg/g)
Citrus/Sour
Caryophyllene16.67%
(22.1mg/g)
Spice/Gas
Linalool4.13%
(5.5mg/g)
Floral/Lavender
Humulene5.22%
(6.9mg/g)
Earthy/Spice
Ocimene0.03%
(0.0mg/g)
Herbal/Sweet
Terpinolene0.1%
(0.1mg/g)
Floral/Herbal
Terpinene0.01%
(0.0mg/g)
Woody/Gasoline
Nerolidol0.55%
(0.7mg/g)
Woody/Floral
Geraniol0.22%
(0.3mg/g)
Rose/Floral
Bisabolol2.53%
(3.4mg/g)
Sweet/Creamy
Borneol0.12%
(0.2mg/g)
Camphor/Spice
Citronellol0.13%
(0.2mg/g)
Rose/Bitter
Alpha-Farnesene2.29%
(3.0mg/g)
Spice/Mace
Beta-Farnesene0.65%
(0.9mg/g)
Floral/Apple
Fenchol0.59%
(0.8mg/g)
Woody/Camphor
Guaiol0.01%
(0.0mg/g)
Woody/Rose
Phellandrene0.01%
(0.0mg/g)
Mint/Citrus
Phytol0.02%
(0.0mg/g)
Grass/Tea
Sabinene0.01%
(0.0mg/g)
Spice/Pine
Gamma-Terpinene0.01%
(0.0mg/g)
Citrus/Lime
Terpineol0.51%
(0.7mg/g)
Floral/Citrus
Valencene0.11%
(0.1mg/g)
Citrus/Woody
Other53%
(70.3mg/g)
Unclassified

MedBud currently tracks 39 common terpenes.

Dosing Look-Up Table (Estimated)

0.01/g7/mg THC0.05/mg CBD
0.05/g35/mg THC0.25/mg CBD
0.1/g70/mg THC0.5/mg CBD
0.15/g105/mg THC0.75/mg CBD
0.2/g140/mg THC1/mg CBD
0.25/g175/mg THC1.25/mg CBD
0.3/g210/mg THC1.5/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United Kingdom Kallie®
Designation
CW-CER T70:G6 Chill Will
Chemotype
Type I: High THC
THC Potential Range (±10%)
63-77%
CBD Potential Range (±10%)
0.5%
CBG Measured
6%
Distributor
United Kingdom Grow® Group UK
Cultivated/Produced in
Flag of Canada Canada
Imported by
United Kingdom Grow® Group UK
Formulated in
Flag of Australia Australia
Formulated by
Australia ACP Pharmaceuticals

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: June

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

About Chilly Willy (aka. Chill Will, Chillywilly)

CWIndica Hybrid

In-house genetics from Sauce Rosin Labs.

Sauce Rosin Labs™ Logo

Proprietary Strain

Chilly Willy is an indica-leaning hybrid created from a cross of "Wilson! Zero" and "Frosted Fruit Cake", it has a distinctive minty flavour with undertones of earthiness.

Exclusively available to Sauce Rosin Labs™.

Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Lynam Pharma Ltd.

Kallie® Logo

Kallie is dedicated to bringing the finest full-spectrum CBPMs, in all their guises, to patients in the UK medical market, with a focus on legacy-derived products and genetics. Kallie takes its name from the Greek word Kalliergo, meaning to cultivate, grow or nurture.

Kalliergo is used to describe the process of developing or improving through careful attention and effort. These are principles Kallie will always look to apply to product, the CBPM industry, and ourselves as an organisation and as individuals.

lynampharma.co.uk

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)